Authors: Buckner, JC Schomberg, PJ McGinnis, WL Cascino, TL Scheithauer, BW O'Fallon, JR Morton, RF Kuross, SA Mailliard, JA Hatfield, AK Cole, JT Steen, PD Bernath, AM

Citation: Jc. Buckner et al., A phase III study of radiation therapy plus carmustine with or without recombinant interferon-alpha in the treatment of patients with newly diagnosedhigh-grade glioma, CANCER, 92(2), 2001, pp. 420-433

Authors: Berenson, JR Rosen, LS Howell, A Parter, L Coleman, RE Morley, W Dreicer, R Kuross, SA Lipton, A Seaman, JJ

Citation: Jr. Berenson et al., Zoledronic acid reduces skeletal-related events in patients with osteolytic metastases - A double-blind, randomized dose-response study, CANCER, 91(7), 2001, pp. 1191-1200

Authors: Burch, PA Block, M Schroeder, G Kugler, JW Sargent, DJ Braich, TA Mailliard, JA Michalak, JC Hatfield, AK Wright, K Kuross, SA

Citation: Pa. Burch et al., Phase III evaluation of octreotide versus chemotherapy with 5-fluorouracilor 5-fluorouracil plus leucovorin in advanced exocrine pancreatic cancer: A north central cancer treatment group study, CLIN CANC R, 6(9), 2000, pp. 3486-3492

Authors: Kirschling, RJ Grill, JP Marks, RS Kugler, JW Gerstner, JB Kuross, SA Michalak, JC Windschitl, HE Krewer, KD Jett, JR

Citation: Rj. Kirschling et al., Paclitaxel and G-CSF in previously untreated patients with extensive stagesmall-cell lung cancer - A phase II study of the North Central Cancer Treatment Group, AM J CL ONC, 22(5), 1999, pp. 517-522